Delivery Order SPE2DB24D2205-SPE2DB25FDXRM

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $25,351.33, is for the delivery of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product, with a period of performance through August 6, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CellCept 500mg tablets, a pharmaceutical product used in various medical treatments. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,034.70 and a period of performance through November 5, 2024. It is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,494.11, is for the delivery of CELLCEPT 500 MG TABLET 100S. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,363.12 delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a specialty medication. The contract has a firm fixed price and a completion date of March 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of CellCept 500 mg tablets. The contract has a ceiling value of $16,893.64 and is a firm fixed-price delivery order with a completion date of November 20, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,702.42, is for the delivery of CellCept 500 mg tablets to support military treatment facilities and federal healthcare programs. It is a firm fixed-price contract with an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,069.14 firm fixed-price delivery order is for the supply of 4,566,810,176 units of the drug CellCept 500 mg tablets. The contract has an ultimate completion date of December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of CellCept 500 mg tablets. The contract is valued at $13,867.86 and has an ultimate completion date of December 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CellCept 500 mg tablets. The $8,140.58 firm-fixed-price contract has an ultimate completion date of September 19, 2024. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, valued at $9,377.75, is for the delivery of 4564312523 - CELLCEPT 500 MG TABLET 100S, a prescription medication. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of April...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXRM
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $19,708.67 and has an ultimate completion date of January 31, 2025.

The contract is for the supply of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen has established itself as a key vendor for the DLA, holding a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 through November 2026 to provide a comprehensive range of pharmaceutical products and medical supplies. This contract serves as a primary vehicle for the DLA to procure essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract was awarded without any set-aside designation, indicating open competition.

Generated 5/4/25, 12:56 AM